Author Topic: Two new MS drugs being developed: umbralisib (TGR-1202), ublituximab (TG-1101)  (Read 230 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
Abstract of a paper on ublituximab presented at the annual ACTRIMS (Americas Committee for Treatment and Research in Multiple Sclerosis) conference in San Diego, February 1-3, 2018. The paper is entitled "6-month results of a Phase 2a multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in relapsing multiple sclerosis."
:


https://actrims.confex.com/actrims/2018/meetingapp.cgi/Paper/2742
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
1 Replies
304 Views
Last post June 03, 2020, 02:57:56 pm
by agate
0 Replies
179 Views
Last post August 09, 2017, 06:07:31 am
by agate
3 Replies
41 Views
Last post February 28, 2023, 04:31:39 pm
by agate
0 Replies
18 Views
Last post October 18, 2023, 03:45:11 pm
by agate
0 Replies
5 Views
Last post February 26, 2024, 08:54:48 pm
by agate